To uncover relevant associations between tumor pathological features, menopausal status, and BC prognosis in relation to intratumoral CYP27A1 expression, we performed immunohistochemistry to quantify CYP27A1 expression in two separate Swedish population-based prospective cohorts of patients with invasive primary BC. The gene discussed is CYP27A1; the disease is neoplasm.